Q1 FY2021 · Press release
Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA) · April 6, 2021 · 4 pages
Read Scholar Rock Holding Corporation's results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional